Chemoinformaics analysis of N-[2-(4-methoxyphenyl)ethyl]benzamide
Molecular Weight | 255.317 | nRot | 5 |
Heavy Atom Molecular Weight | 238.181 | nRig | 13 |
Exact Molecular Weight | 255.126 | nRing | 2 |
Solubility: LogS | -3.394 | nHRing | 0 |
Solubility: LogP | 2.741 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
nHA | 2 | APOL | 40.7595 |
nHD | 1 | BPOL | 20.2285 |
QED | 0.892 |
Synth | 1.334 |
Natural Product Likeliness | -0.784 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.18 |
Pgp-sub | 0.034 |
HIA | 0.006 |
CACO-2 | -4.631 |
MDCK | 0.0000161 |
BBB | 0.401 |
PPB | 0.956561 |
VDSS | 0.975 |
FU | 0.0296644 |
CYP1A2-inh | 0.952 |
CYP1A2-sub | 0.889 |
CYP2c19-inh | 0.963 |
CYP2c19-sub | 0.357 |
CYP2c9-inh | 0.896 |
CYP2c9-sub | 0.898 |
CYP2d6-inh | 0.927 |
CYP2d6-sub | 0.884 |
CYP3a4-inh | 0.699 |
CYP3a4-sub | 0.433 |
CL | 8.44 |
T12 | 0.622 |
hERG | 0.592 |
Ames | 0.337 |
ROA | 0.028 |
SkinSen | 0.55 |
Carcinogencity | 0.214 |
EI | 0.191 |
Respiratory | 0.037 |
NR-Aromatase | 0.02 |
Antiviral | No |
Prediction | 0.675865 |